Replies to post #521815 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

NWBO, or the company buying NWBO, will have to start other P3 DCVAX trials for other solid tumor organ cancer indications such as lung, liver, prostate etc to prove efficiency and then submit the request for approval.

At the phase the request for approval for GBM is going we are looking well beyond the 2030s for other organ cancers

[Bob_LobLaw]

Could be prescribed off label perhaps but might not get insurance coverage.

[HappyLibrarian]

Hard experience has taught astute NWBO investors that burning away more time on the from end of the process does immunize us from waiting the standard length of time (or longer) on the back end.

Extra waiting is consistently revealed to be just wasted lives and time and neither can be gotten back. It buys you nothing extra for later.

To paraphrase one expert who business leaders look to “I have never heard of a successful conflict that was drawn out.”